Suppr超能文献

致病性分枝杆菌通过抑制尼曼-匹克C型病细胞途径实现细胞持久性。

Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway.

作者信息

Fineran Paul, Lloyd-Evans Emyr, Lack Nathan A, Platt Nick, Davis Lianne C, Morgan Anthony J, Höglinger Doris, Tatituri Raju Venkata V, Clark Simon, Williams Ian M, Tynan Patricia, Al Eisa Nada, Nazarova Evgeniya, Williams Ann, Galione Antony, Ory Daniel S, Besra Gurdyal S, Russell David G, Brenner Michael B, Sim Edith, Platt Frances M

机构信息

Department of Pharmacology, University of Oxford, Oxford, UK.

School of Biosciences, Cardiff University, Cardiff, UK.

出版信息

Wellcome Open Res. 2016 Nov 18;1:18. doi: 10.12688/wellcomeopenres.10036.2.

Abstract

BACKGROUND

Tuberculosis remains a major global health concern. The ability to prevent phagosome-lysosome fusion is a key mechanism by which intracellular mycobacteria, including , achieve long-term persistence within host cells. The mechanisms underpinning this key intracellular pro-survival strategy remain incompletely understood. Host macrophages infected with persistent mycobacteria share phenotypic similarities with cells taken from patients suffering from Niemann-Pick Disease Type C (NPC), a rare lysosomal storage disease in which endocytic trafficking defects and lipid accumulation within the lysosome lead to cell dysfunction and cell death. We investigated whether these shared phenotypes reflected an underlying mechanistic connection between mycobacterial intracellular persistence and the host cell pathway dysfunctional in NPC.

METHODS

The induction of NPC phenotypes in macrophages from wild-type mice or obtained from healthy human donors was assessed via infection with mycobacteria and subsequent measurement of lipid levels and intracellular calcium homeostasis. The effect of NPC therapeutics on intracellular mycobacterial load was also assessed.

RESULTS

Macrophages infected with persistent intracellular mycobacteria phenocopied NPC cells, exhibiting accumulation of multiple lipid types, reduced lysosomal Ca levels, and defects in intracellular trafficking. These NPC phenotypes could also be induced using only lipids/glycomycolates from the mycobacterial cell wall. These data suggest that persistent intracellular mycobacteria inhibit the NPC pathway, likely via inhibition of the NPC1 protein, and subsequently induce altered acidic store Ca homeostasis. Reduced lysosomal calcium levels may provide a mechanistic explanation for the reduced levels of phagosome-lysosome fusion in mycobacterial infection. Treatments capable of correcting defects in NPC mutant cells via modulation of host cell calcium were of benefit in promoting clearance of mycobacteria from infected host cells.

CONCLUSION

These findings provide a novel mechanistic explanation for mycobacterial intracellular persistence, and suggest that targeting interactions between the mycobacteria and host cell pathways may provide a novel avenue for development of anti-TB therapies.

摘要

背景

结核病仍然是全球主要的健康问题。防止吞噬体 - 溶酶体融合的能力是包括[未提及具体菌名]在内的细胞内分枝杆菌在宿主细胞内长期存活的关键机制。支撑这一关键细胞内促生存策略的机制仍未完全明确。感染持续性分枝杆菌的宿主巨噬细胞与患有尼曼 - 匹克病C型(NPC)患者的细胞具有表型相似性,NPC是一种罕见的溶酶体贮积病,其中内吞运输缺陷和溶酶体内脂质积累导致细胞功能障碍和细胞死亡。我们研究了这些共同表型是否反映了分枝杆菌细胞内持续性与NPC中功能失调的宿主细胞途径之间潜在的机制联系。

方法

通过用分枝杆菌感染并随后测量脂质水平和细胞内钙稳态,评估野生型小鼠或健康人类供体来源的巨噬细胞中NPC表型的诱导情况。还评估了NPC治疗药物对细胞内分枝杆菌载量的影响。

结果

感染持续性细胞内分枝杆菌的巨噬细胞表现出与NPC细胞相似的表型,包括多种脂质类型的积累、溶酶体钙水平降低以及细胞内运输缺陷。这些NPC表型也可以仅使用分枝杆菌细胞壁的脂质/糖脂来诱导。这些数据表明,持续性细胞内分枝杆菌可能通过抑制NPC1蛋白来抑制NPC途径,随后诱导酸性钙库的钙稳态改变。溶酶体钙水平降低可能为分枝杆菌感染中吞噬体 - 溶酶体融合水平降低提供一种机制解释。能够通过调节宿主细胞钙来纠正NPC突变细胞缺陷的治疗方法有助于促进分枝杆菌从感染的宿主细胞中清除。

结论

这些发现为分枝杆菌细胞内持续性提供了一种新的机制解释,并表明针对分枝杆菌与宿主细胞途径之间的相互作用可能为抗结核治疗的开发提供一条新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c70/5482350/0409b26c372b/wellcomeopenres-1-12858-g0000.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验